ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KHRNF Khiron Life Sciences Corporation (CE)

0.000001
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Khiron Life Sciences Corporation (CE) USOTC:KHRNF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

The Cannabis Report Model Portfolio June 26, 2020

30/06/2020 1:01pm

InvestorsHub NewsWire




PUBLISHED:  Jun 30 2020 10:29

I would like to wish all of our American subscribers a happy and safe Fourth of July and I also hope all of our Canadian subscribers have a happy and safe Canada Day.

Highlights: all currency references in this report are Canadian dollars except where noted otherwise

  • The model portfolio had a reasonable week easing -2.1% compared with -1.8% for the Let’s Toke Business Marijuana Composite Index and a drop of -6.3% in the MJ Canada Index as adjusted.
  1. The star of the portfolio last week was Sunniva (OTCMKTS: SNNVF) that closed at $0.17 per share for a gain of +6.9%. This is a great example of something that confuses many investors, namely, how does a stock rise when the company has just reported receiving a Cease Trading Order? There are many ways to try to explain it but here is one of my favourites. The stock market not a thermometer; it is a barometer. In other words, a thermometer tells you what the temperature is at present. A barometer gives you an indication of what the weather will be in the future. So SNNVF rising tells you what investors believe Sunniva’s future looks like and not how it is today.
  2. IM Cannabis Corp. (CSE: IMCC) maintained its position as the largest holding in the portfolio. IMCC actually had a very positive week moving up to an all-time high of $1.34 per share before settling back to close at $1.18 per share. This was still a healthy +4.4% advance in a week where most of the indexes were lower. This week IMCC announced that in a peer reviewed study, two of the IM Cannabis branded strains recorded an improvement in those with migraine headaches in 60% of cases.

To read more from Ted Ohashi including an interview with the Chief Executive Officer of Khiron Life SciencesCLICK HERE

1 Year Khiron Life Sciences (CE) Chart

1 Year Khiron Life Sciences (CE) Chart

1 Month Khiron Life Sciences (CE) Chart

1 Month Khiron Life Sciences (CE) Chart

Your Recent History

Delayed Upgrade Clock